| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
25,430.90
|
|
Change (%)
|
-53.65 (-0.21%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
25,250.00
-
25,473.55
|
|
52-Week Range (RS)
|
25,164.00
-
35,921.55
|
|
Beta (1 Year)
|
0.28
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| Abbott India standalone net profit rises 4.21% in the December 2025 quarter |
| Abbott India Q3 PAT jumps 4% YoY to Rs 376 cr |
| Abbott India to announce Quarterly Result |
| Volumes soar at Abbott India Ltd counter |
| Abbott India Ltd slips for fifth straight session |
| Volumes soar at Abbott India Ltd counter |
| Abbott India gets central govt nod to appoint Kartik Rajendran as MD |
| Abbott India receives Central Govt. approval for appointment of MD |
| Abbott India standalone net profit rises 15.80% in the September 2025 quarter |
| Abbott India Q2 PAT jumps 16% YoY to Rs 415 cr |
|
|
|
| Incoporation Year : 1944 |
| Chairman : Munir Shaikh |
| Ownership Group : MNC Asc-Abbott |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Abbott India Ltd
Unit No 3 Corporate Park,
Sion Trombay Road Chembur,
Mumbai,
Maharashtra-400071 |
Phone:91-22-67978888/50461000/2000/1119
Fax:91-22-50169400 |
| E-Mail : investorrelations.india@abbott.com; webmaster@abbo |
| URL : http://www.abbott.co.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
23-Apr-2026 |
25422.50 |
0.03 |
| 1Month |
30-Mar-2026 |
25923.05 |
-1.90 |
| 3Month |
30-Jan-2026 |
27675.00 |
-8.11 |
| 6Month |
30-Oct-2025 |
29635.15 |
-14.19 |
| 1Year |
30-Apr-2025 |
29876.95 |
-14.88 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Large & Midcap Fund |
2.04 |
712.35 |
| AXIS Midcap Fund |
1.46 |
422.02 |
| Canara Robeco Large and Mid Cap Fund |
1.62 |
359.74 |
| Nippon India Multi Cap Fund |
0.67 |
310.86 |
| PGIM India Midcap Fund |
1.99 |
192.55 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Glaxosmithkline Pharmaceuticals Ltd |
2,335.60 |
-1.49 |
3,515.95 |
2,218.00 |
39,566.47 |
| Pfizer Ltd |
4,708.15 |
-1.18 |
5,987.65 |
4,156.65 |
21,538.72 |
| Astrazeneca Pharma India Ltd |
8,217.20 |
-1.95 |
10,653.05 |
7,630.00 |
20,543.00 |
| Sanofi Consumer Healthcare India Ltd |
4,764.65 |
-0.72 |
5,954.00 |
3,950.50 |
10,973.29 |
| Procter & Gamble Health Ltd |
5,194.55 |
1.33 |
6,700.00 |
4,699.70 |
8,622.63 |
|
|
|
|